Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer

Published:2019-11 Issue: Volume:181 Page:111535
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Xin,Yu Chenhua,Wang Cheng,Ma Yakun,Wang Tianqi,Li Yao,Huang Zhi,Zhou Manqian,Sun Peiqing,Zheng Jianyu,Yang Shengyong^ORCID,Fan Yan,Xiang Rong

Funder

Project of Science and Technology Assistance in Developing Countries

Natural Science Foundation of Tianjin

Fundamental Research Funds for the Central Universities, Nankai University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference58 articles.

1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2018

2. Identification of selective inhibitors of cancer stem cells by high-throughput screening;Gupta;Cell,2009

3. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission;Hirsch;Cancer Res.,2009

4. Non-coding RNAs in cancer stem cells;Yan;Cancer Lett.,2018

5. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells;Burnett;Cancer Lett.,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 inhibitors for the treatment of solid tumors;Biochemical Pharmacology;2024-11

2. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer;Current Signal Transduction Therapy;2024-07

3. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer;Frontiers in Pharmacology;2024-04-12

4. Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer;Journal of Medicinal Chemistry;2023-10-23

5. Current Developments of Pyrrolo[2,3-d]pyrimidines with Anticancer Potential (A Review);Russian Journal of General Chemistry;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3